Molecular dynamics simulation of oseltamivir resistance in neuraminidase of avian influenza H5N1 virus

Journal of Molecular Modeling

Volumn 17, Issue 3, 2011, Pages 587-592

  Shu, Mao ^a   Lin, Zhihua ^a   Zhang, Yunru ^a   Wu, Yuqian ^b   Mei, Hu ^b   Jiang, Yongjun ^c  

^a CHONGQING UNIVERSITY OF TECHNOLOGY   (China)

^b CHONGQING UNIVERSITY   (China)

^c ZHEJIANG UNIVERSITY   (China)

Author keywords

Influenza virus; Molecular dynamics simulations; Neuraminidase; Oseltamivir

Indexed keywords

CARBOXYLIC ACID; OSELTAMIVIR; PROTEIN INHIBITOR; PROTEIN M2; SIALIDASE; SIALIDASE INHIBITOR;

ANTIVIRAL RESISTANCE; ARTICLE; HYDROGEN BOND; INFECTION CONTROL; INFLUENZA VIRUS A H5N1; MOLECULAR DYNAMICS; MUTATION RATE; NONHUMAN; PRIORITY JOURNAL; VIRUS MUTANT; VIRUS MUTATION; VIRUS STRAIN; VIRUS VIRULENCE;

AMINO ACID SUBSTITUTION; ANTIVIRAL AGENTS; BINDING SITES; DRUG RESISTANCE, VIRAL; ENZYME INHIBITORS; INFLUENZA A VIRUS, H5N1 SUBTYPE; MOLECULAR DYNAMICS SIMULATION; NEURAMINIDASE; OSELTAMIVIR;

AVES; AVIAN INFLUENZA VIRUS; ORTHOMYXOVIRIDAE;

EID: 79954432061     PISSN: 16102940     EISSN: 09485023     Source Type: Journal    
DOI: 10.1007/s00894-010-0757-x     Document Type: Article

References (35)

1. M Enserink 2005 Avian influenza: pandemic influenza: global update Science 309 370 371 10.1126/science.309.5733.370 (Pubitemid 40994660)
2. MD de Jong TT Hien 2006 Avian influenza A (H5N1) J Clin Virol 35 2 13 10.1016/j.jcv.2005.09.002 (Pubitemid 43020946)
3. PM Colman 1994 Influenza virus neuraminidase: structure, antibodies, and inhibitors Protein Sci 3 1687 1696 10.1002/pro.5560031007 1:CAS:528: DyaK2MXit1yjs78%3D (Pubitemid 24356591)
4. MN Matrosovich TY Matrosovich T Gray, et al. 2004 Neuraminidase is important for the initiation of influenza virus infection in human airway epithelium J Virol 78 12665 12667 10.1128/JVI.78.22.12665-12667.2004 1:CAS:528:DC%2BD2cXhtVWhu7fJ (Pubitemid 39458784)
5. RG Douglas Jr 1990 Prophylaxis and treatment of influenza N Engl J Med 322 443 450 10.1056/NEJM199002153220706
6. SM Wintermeyer MC Nahata 1995 Rimantadine: a clinical perspective Ann Pharmacother 29 299 310 1:STN:280:DyaK2MzivFyisw%3D%3D
7. LH Pinto LJ Holsinger RA Lamb 1992 Influenza virus M2 protein has ion channel activity Cell 69 517 528 10.1016/0092-8674(92)90452-I 1:CAS:528:DyaK38Xks1Cqtrg%3D
8. Hay AJ et al (1993) In: Hannoun CE (ed) Options for the control of influenza virus II. Excerpta Medica, Amsterdam, pp 281-288
9. T Jefferson V Demicheli D Rivetti, et al. 2006 Antivirals for influenza in healthy adults: systematic review Lancet 367 303 313 10.1016/S0140-6736(06) 67970-1 1:CAS:528:DC%2BD28XnvVWktw%3D%3D (Pubitemid 43151463)
10. LV Gubareva L Kaiser MN Matrosovich, et al. 2001 Selection of influenza virus mutants in experimentally infected volunteers treated with oseltamivir J Infect Dis 183 523 531 10.1086/318537 1:CAS:528:DC%2BD3MXhsVWrtLg%3D (Pubitemid 32147507)
11. JL McKimm-Breschkin 2000 Resistance of influenza viruses to neuraminidase inhibitors-a review Antiviral Res 47 1 17 10.1016/S0166-3542(00)00103-0 1:CAS:528:DC%2BD3cXltlWgsrk%3D (Pubitemid 30621392)
12. A Moscona 2005 Oseltamivir resistance-disabling our influenza defenses N Engl J Med 353 2633 2636 10.1056/NEJMp058291 1:CAS:528:DC%2BD2MXhtlarsr3P (Pubitemid 41817709)
13. O Ferraris B Lina 2008 Mutations of neuraminidase implicated in neuraminidase inhibitors resistance J Clin Virol 41 13 19 10.1016/j.jcv.2007.10. 020 1:CAS:528:DC%2BD1cXhtlGmug%3D%3D (Pubitemid 350298978)
14. SA Adcock JA McCammon 2006 Molecular dynamics: survey of methods for simulating the activity of proteins Chem Rev 106 1589 1615 10.1021/cr040426m 1:CAS:528:DC%2BD28Xht1eqtro%3D (Pubitemid 43792773)
15. WF van Gusteren D Bakowies R Baron, et al. 2006 Biomolecular modeling: goals, problems, perspectives Angew Chem Int Ed Eng 45 4064 4092 10.1002/anie.200502655 (Pubitemid 44105659)
16. AW Ravna I Sylte SG Dahl 2009 Structure and localisation of drug binding sites on neurotransmitter transporters J Mol Model 15 1155 1164 10.1007/s00894-009-0478-1 1:CAS:528:DC%2BC3cXlslGjt7g%3D
17. KM Masukawa PA Kollman ID Kuntz 2003 Investigation of Neuraminidase Substrate Recognition Using Molecular Dynamics and Free Energy Calculations J Med Chem 46 5628 5637 10.1021/jm030060q 1:CAS:528:DC%2BD3sXpt1Wqsbo%3D (Pubitemid 37543314)
18. M Malaisree T Rungrotmongkol P Decha, et al. 2008 Understanding of known drug-target interactions in the catalytic pocket of neuraminidase subtype N1 Proteins 17 1908 1918 10.1002/prot.21897 (Pubitemid 351732944)
19. M Malaisree T Rungrotmongkol N Nunthaboot, et al. 2009 Source of oseltamivir resistance in avian influenza H5N1 virus with the H274Y mutation Amino Acids 37 725 732 10.1007/s00726-008-0201-z 1:CAS:528:DC%2BD1MXhtFyqt7jI
20. T Udommaneethanakit T Rungrotmongkol U Bren, et al. 2009 Dynamic behavior of avian influenza a virus neuraminidase subtype H5N1 in complex with oseltamivir, zanamivir, peramivir, and their phosphonate analogues J Chem Inf Model 49 2323 2332 10.1021/ci900277r 1:CAS:528:DC%2BD1MXhtFOks73E
21. RE Amaro DD Minh LS Cheng, et al. 2007 Remarkable loop flexibility in avian influenza N1 and its implications for antiviral drug design J Am Chem Soc 129 7764 7765 10.1021/ja0723535 1:CAS:528:DC%2BD2sXmtVKmtLY%3D (Pubitemid 46998169)
22. MR Landon RE Amaro R Baron, et al. 2008 Novel druggable hot spots in avian influenza neuraminidase H5N1 revealed by computational solvent mapping of a reduced and representative receptor ensemble Chem Biol Drug Des 71 106 116 10.1111/j.1747-0285.2007.00614.x 1:CAS:528:DC%2BD1cXisFSntbg%3D (Pubitemid 351160979)
23. MA Rameix-Welti F Agou P Buchy, et al. 2006 Natural variation can significantly alter the sensitivity of influenza A (H5N1) viruses to oseltamivir Antimicrob Agents Chemother 50 3809 3815 10.1128/AAC.00645-06 1:CAS:528:DC%2BD28XhtFOkt7nF (Pubitemid 44684897)
24. EA Govorkova NA Ilyushina DA Boltz A Douglas N Yilmaz RG Webster 2007 Efficacy of oseltamivir therapy in ferrets inoculated with different clades of H5N1 influenza virus Antimicrob Agents Chemother 51 1414 1424 10.1128/AAC.01312-06 1:CAS:528:DC%2BD2sXktlOjtb4%3D (Pubitemid 46586824)
25. JL McKimm-Breschkin PW Selleck TB Usman, et al. 2007 Reduced sensitivity of influenza A (H5N1) to oseltamivir Emerging Infectious Diseases 13 1354 1357 1:CAS:528:DC%2BD2sXhtVygtbjO (Pubitemid 47510297)
26. RJ Russell LF Haire DJ Stevens, et al. 2006 The structure of H5N1 avian influenza neuraminidase suggests new opportunities for drug design Nature 443 45 49 10.1038/nature05114 1:CAS:528:DC%2BD28XptFCmur4%3D (Pubitemid 44344043)
27. Frisch MJ, Trucks GW, Schlegel HB et al (1998) Gaussian98, Revision A.7. Gaussian Inc, Pittsburgh, PA
28. C Bayly P Cieplak W Cornell, et al. 1993 A well-behaved electrostatic potential based method using charge restraints for deriving atomic charges-the RESP model J Phys Chem 97 10269 10280 10.1021/j100142a004 1:CAS:528: DyaK3sXlvVyqsLs%3D
29. J Wang W Wang PA Kollman, et al. 2006 Automatic atom type and bond type perception in molecular mechanical calculations J Mol Graph Model 25 2 247 260 10.1016/j.jmgm.2005.12.005 (Pubitemid 44363172)
30. WL Jorgensen J Chandrasekhar J Madura, et al. 1983 Comparison of simple potential functions for simulating liquid water J Chem Phys 79 926 935 10.1063/1.445869 1:CAS:528:DyaL3sXksF2htL4%3D
31. Y Duan C Wu S Chowdhury MC Lee, et al. 2003 A point-charge force field for molecular mechanics simulations of proteins based on condensed-phase quantum mechanical calculations J Comput Chem 24 1999 2012 10.1002/jcc.10349 1:CAS:528:DC%2BD3sXovVygsbc%3D
32. MC Lee Y Duan 2004 Distinguish protein decoys using a scoring function based on AMBER force field, short molecular dynamics simulations and the generalized born solvent model Proteins 55 3 620 634 10.1002/prot.10470 1:CAS:528:DC%2BD2cXjvFemtL8%3D (Pubitemid 38620087)
33. J Wang RM Wolf JW Caldwell, et al. 2004 Development and testing of a general Amber force field J Comput Chem 25 1157 1174 10.1002/jcc.20035 1:CAS:528:DC%2BD2cXksFakurc%3D
34. T Darden D York L Pedersen 1993 Particle mesh Ewald-an Nlog(N) method for Ewald sums in large systems J Chem Phy 98 10089 10092 10.1063/1.464397 1:CAS:528:DyaK3sXks1Ohsr0%3D
35. JP Ryckaert G Ciccotti HJC Berendsen 1977 Numerical integration of the Cartesian equations of motion of a system with constraints: molecular dynamics of n-alkanes J Comput Phys 23 327 341 10.1016/0021-9991(77)90098-5 1:CAS:528:DyaE2sXktVGhsL4%3D